Number of participants using pre-exposure prophylaxis (PreP) (or used in the previous 3 months) and the likelihood of future PreP use by age and country of residence
| n (%) | Currently taking PrEP,n (%) | Not currently taking PrEP,n (%) | Likelihood of future PrEP use,M (SD) | |
| Age | ||||
| 18–25 | 3065 (29.0) | 219 (7.1) | 2846 (92.9) | 2.89 (1.12) |
| 26–30 | 2095 (19.9) | 219 (10.5) | 1876 (89.5) | 2.91 (1.19) |
| 31–40 | 2948 (27.9) | 324 (11.0) | 2624 (89.0) | 2.91 (1.22) |
| 41–50 | 1680 (15.9) | 222 (13.2) | 1458 (86.8) | 3.02 (1.30) |
| 51–60 | 620 (5.9) | 65 (10.5) | 555 (89.5) | 2.98 (1.26) |
| 61–70 | 123 (1.2) | 16 (13.0) | 107 (87.0) | 2.86 (1.31) |
| >70 | 20 (0.2) | 2 (10.0) | 18 (90.0) | 3.12 (1.05) |
| Total | n=10 551 | 1067 (10.1) | 9484 (89.9) | 2.93 (1.21) |
| Country of residence | ||||
| France | 2544 (24.1) | 281 (11.0) | 2263 (89.0) | 3.08 (1.29) |
| Russia | 2393 (22.7) | 195 (8.1) | 2198 (91.9) | 2.84 (1.06) |
| UK | 1414 (13.4) | 146 (10.3) | 1268 (89.7) | 2.93 (1.30) |
| Italy | 797 (7.5) | 50 (6.3) | 747 (93.7) | 2.60 (1.11) |
| Turkey | 617 (5.8) | 99 (16.0) | 518 (84.0) | 3.13 (1.13) |
| Ukraine | 374 (3.5) | 62 (16.6) | 312 (83.4) | 3.01 (1.10) |
| Germany | 309 (2.9) | 30 (9.7) | 279 (90.3) | 2.75 (1.33) |
| Belgium | 209 (2.0) | 19 (9.1) | 190 (90.9) | 3.29 (1.13) |
| Belarus | 195 (1.8) | 17 (8.7) | 178 (91.3) | 2.92 (1.03) |
| Spain | 183 (1.7) | 13 (7.1) | 170 (92.9) | 2.76 (1.15) |
| The Netherlands | 158 (1.5) | 21 (13.3) | 137 (86.7) | 3.01 (1.29) |
| Denmark | 145 (1.4) | 14 (9.7) | 131 (90.3) | 2.65 (1.21) |
| Switzerland | 134 (1.3) | 8 (6.0) | 126 (94.0) | 2.65 (1.34) |
| Portugal | 131 (1.2) | 6 (4.5) | 125 (95.4) | 3.07 (1.10) |
| Sweden | 117 (1.1) | 18 (15.4) | 99 (84.6) | 3.05 (1.36) |
| Other | 842 (8.0) | 92 (10.9) | 750 (89.1) | 2.83 (1.16) |
| Total | n=10 562 | n=1071 (10.1) | n=9491 (89.9) | 2.93 (1.21) |